secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0001558370-22-012967
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta to acquire B Medical Systems for €410M cash plus €50M earnout
--------------------------------------------------------------------

- Cash purchase price €410M; up to €50M additional contingent consideration based on performance milestones.
- B Medical generated ~€109M revenue in last twelve months ending June 30, 2022.
- Transaction expected to close in October 2022, subject to customary conditions.
- Acquisition expected to be accretive to non-GAAP earnings in FY2023 and GAAP earnings in FY2024.
- B Medical CEO Luc Provost and Deputy CEO Jesal Doshi expected to remain with Azenta.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837022012967/0001558370-22-012967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837022012967/azta-20220808x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-012967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer